The annual biovigilance report includes all serious adverse events and reactions occurring during the treatment and use of substances of human origin from 1 January 2023 to 30 June 2024. In 2023, the reproductive system accounted for the majority of notifications.

Press release from the Belgian Debt Agency

Press release of the Belgian Federal Debt Agency

Press release from the Belgian Debt Agency

Press release from the Belgian Debt Agency

In April 2024, the Critical Medicines Alliance was established under the Belgian Presidency of the Council of the European Union. The goal of the Alliance is to foster collaboration among policymakers and stakeholders, and develop a robust and responsive system for the supply of critical medicines in the European Union. Today, on 28 February 2025, the Critical Medicines Alliance presents its strategic report. This report will be used as the basis for new European legislation on medicines...

Press release from the Belgian Debt Agency

The Belgian Debt Agency informs you that the range for the upcoming auction on Monday 24 February 2025, has been determined at EUR 2.6/3 billion

Since the introduction of the NIS2 legislation in October last year, 1224 organisations from critical sectors have already registered with the Centre for Cybersecurity Belgium (CCB). During this period, the number of reports of cyber incidents increased by 50%.